Effects of Rifaximin on Urgency, Bloating, and Abdominal Pain in Patients With IBS-D: A Randomized, Controlled, Repeat Treatment Study

被引：0
|
作者：
Chey, William D.
Chang, Lin
Lembo, Anthony
Aggarwal, Kavita
Bortey, Enoch
Paterson, Craig
Forbes, William P.
机构：
来源：
GASTROENTEROLOGY | 2015年 / 148卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
313
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [31] Assessing the Efficacy of Rifaximin in Diarrhea-Predominant Irritable Syndrome (IBS-D): A Post hoc Analysis of 2 Phase 3, Randomized, Placebo-Controlled Trials
    Pimentel, Mark
    Cash, Brooks D.
    Lacy, Brian E.
    Heimanson, Zeev
    Lembo, Anthony J.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S254 - S254
  • [32] Efficacy of Oral Ibodutant in IBS-D Female Patients Measured by Abdominal Pain Severity - An Iris 2 Post-Hoc Analysis
    Tack, Jan F.
    Scartoni, Simona
    Tonini, Giulia
    Schumacher, Kai
    Ott, Kerstin
    Koch, Ines
    Otranto, Isabella
    Bertolotti, Monica
    Capriati, Angela
    Maggi, Carlo A.
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S491 - S491
  • [33] FMT WITH OR WITHOUT ANTIBIOTIC PRETREATMENT IN PATIENTS WITH IBS-D: RESULTS OF A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
    Singh, Prashant
    Nee, Judy
    Iturrino-Moreda, Johanna
    Wong, Wing Fei
    Budree, Shrish
    Kassam, Zain
    Kelley, John
    Cheng, Vivian
    Hirsch, William
    Lembo, Anthony
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S235 - S235
  • [34] The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study
    Bardhan, KD
    Forbes, A
    Marsden, CL
    Mason, T
    Short, G
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (02) : 213 - 222
  • [35] Antibiotic Susceptibility of Skin Swab Staphylococcus Isolates From Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Treated With Repeat Courses of Rifaximin Showed No Evidence of Resistance
    Schoenfeld, Philip
    Pimentel, Mark
    Cash, Brooks D.
    Wolf, Ray A.
    Olin, Jason T.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S751 - S751
  • [36] Association between symptoms in irritable bowel syndrome with diarrhea (IBS-D): A pooled correlation and tricomposite endpoint analysis of two phase 3, randomized, placebo-controlled, rifaximin trials
    Staller, K.
    Lacy, B. E.
    Sayuk, G. S.
    Rao, S. S. C.
    Karsan, H. A.
    Neshatiana, L.
    Lunsford, T. N.
    Allen, C.
    Heimanson, Z.
    Brenner, D. M.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2023, 35
  • [37] The effect of eye movement desensitization and reprocessing (EMDR) on abdominal pain in patients with irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial (EMDR4IBS)
    Wertheim, B.
    Aarts, E. E.
    de Roos, C.
    van Rood, Y. R.
    [J]. TRIALS, 2023, 24 (01)
  • [38] The effect of eye movement desensitization and reprocessing (EMDR) on abdominal pain in patients with irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial (EMDR4IBS)
    B. Wertheim
    E. E. Aarts
    C. de Roos
    Y. R. van Rood
    [J]. Trials, 24
  • [39] Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain-Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study
    Fichna, Jakub
    Wood, JodiAnne T.
    Papanastasiou, Malvina
    Vadivel, Subramanian K.
    Oprocha, Piotr
    Salaga, Maciej
    Sobczak, Marta
    Mokrowiecka, Anna
    Cygankiewicz, Adam I.
    Zakrzewski, Piotr K.
    Malecka-Panas, Ewa
    Krajewska, Wanda M.
    Koscielniak, Piotr
    Makriyannis, Alexandros
    Storr, Martin A.
    [J]. PLOS ONE, 2013, 8 (12):
  • [40] Treatment-free interval (TFI): A novel approach to assessing real-world treatment response among patients with irritable Bowel syndrome with diarrhea (IBS-D) treated with rifaximin or eluxadoline
    Lacy, B. E.
    Gagnon-Sanschagrin, P.
    Heimanson, Z.
    Bungay, R.
    Bellefleur, R.
    Guerin, A.
    Dashputre, A.
    Bumpass, B.
    Borroto, D.
    Joseph, G.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2023, 35
12345